The Sigma-2 Receptor/TMEM97 Agonist PB28 Suppresses Cell Proliferation and Invasion by Regulating the PI3K-AKT-mTOR Signalling Pathway in Renal Cancer.

J Cell Mol Med · 2021 · PMC8650047 · PMID 34783163

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Therefore, the proliferative, migratory and invasive abilities of renal cancer cells showed an increasing trend when sigma‐2 receptor antagonist 1 was added to the cells.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.